Comparative 12-week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real-world multicenter retrospective study.

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)

Keyphrases